Evidence map›Paper›PMID 26244770›Full record

ArticlePloS one2015

An Origin of Cooperative Oxygen Binding of Human Adult Hemoglobin: Different Roles of the α and β Subunits in the α2β2 Tetramer.

Shigenori Nagatomo, Yukifumi Nagai, Yayoi Aki, Hiroshi Sakurai, Kiyohiro Imai, Naoki Mizusawa, Takashi Ogura, Teizo Kitagawa, Masako Nagai

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Pathophysiological mechanisms in severe preeclampsia: role of upregulated proteins in blood pressure, extracellular matrix and immunity.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. A New Model of Hemoglobin Oxygenation.Entropy (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Designed leucine-rich repeat proteins bind two muramyl dipeptide ligands.Protein science : a publication of the Protein Society · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shigenori NagatomoDepartment of Chemistry, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Yukifumi NagaiResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
Yayoi AkiResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
Hiroshi SakuraiResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
Kiyohiro ImaiResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
Naoki MizusawaResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan; Research Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
Takashi OguraResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
Teizo KitagawaResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
Masako NagaiResearch Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan; Research Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, Japan,3 School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan,4 Department of Frontier Biosciences, Hosei University, Koganei, Tokyo, Japan,5 Picobiology Institute, Graduate School of Life Science, University of Hyogo, RSC-UH Leading Program Center, Sayo, Sayo-gun, Hyogo, Japan.
University of Hyogo · JPKanazawa University · JPHosei University · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human hemoglobin (Hb), which is an α2β2 tetramer and binds four O2 molecules, changes its O2-affinity from low to high as an increase of bound O2, that is characterized by 'cooperativity'. This property is indispensable for its function of O2 transfer from a lung to tissues and is accounted for in terms of T/R quaternary structure change, assuming the presence of a strain on the Fe-histidine (His) bond in the T state caused by the formation of hydrogen bonds at the subunit interfaces. However, the difference between the α and β subunits has been neglected. To investigate the different roles of the Fe-His(F8) bonds in the α and β subunits, we investigated cavity mutant Hbs in which the Fe-His(F8) in either α or β subunits was replaced by Fe-imidazole and F8-glycine. Thus, in cavity mutant Hbs, the movement of Fe upon O2-binding is detached from the movement of the F-helix, which is supposed to play a role of communication. Recombinant Hb (rHb)(αH87G), in which only the Fe-His in the α subunits is replaced by Fe-imidazole, showed a biphasic O2-binding with no cooperativity, indicating the coexistence of two independent hemes with different O2-affinities. In contrast, rHb(βH92G), in which only the Fe-His in the β subunits is replaced by Fe-imidazole, gave a simple high-affinity O2-binding curve with no cooperativity. Resonance Raman, 1H NMR, and near-UV circular dichroism measurements revealed that the quaternary structure change did not occur upon O2-binding to rHb(αH87G), but it did partially occur with O2-binding to rHb(βH92G). The quaternary structure of rHb(αH87G) appears to be frozen in T while its tertiary structure is changeable. Thus, the absence of the Fe-His bond in the α subunit inhibits the T to R quaternary structure change upon O2-binding, but its absence in the β subunit simply enhances the O2-affinity of α subunit.

Indexed as

Protein MultimerizationProtein Structure, QuaternaryAdultalpha-Globinsbeta-GlobinsCircular DichroismGlycineHemoglobinsHistidineHumansHydrogen BondingImidazolesIronMagnetic Resonance SpectroscopyModels, MolecularOxygenalpha-Globinsbeta-GlobinsdeoxyhemoglobinGlycineHemoglobinsHistidineImidazolesIronOxygen

Identifiers

PMID26244770
PMCPMC4526547
OpenAlexW1093988844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.